Pharmaceutical giant Merck has sold all of the assets of its Vree Health subsidiary to San Diego-based PatientSafe solutions for an undisclosed amount. Joe Condurso The deal is expected to close in early 2018, according to a press release from Merck's parent company, Johnson & Johnson. This will likely integrate with PatientSafe's main product, PatientTouch, a care coordination offering for teams, commonly used in medication administration and infant care.
Pharmaceutical giant Merck has sold all of the assets of its Vree Health subsidiary to San Diego-based PatientSafe solutions for an undisclosed amount. The deal is expected to close in early 2018, according to a press release from Merck's parent company, Johnson & Johnson. This will likely integrate with PatientSafe's main product, PatientTouch, a care coordination offering for teams, commonly used in medication administration and infant care.